Pfeiffenberger Brent 4

What Happened
Brent Pfeiffenberger, President, CEO and a Director of Century Therapeutics, had 31,172 shares disposed (withheld) to satisfy tax withholding obligations tied to the vesting of restricted stock units. The reported per-share value was $1.75, for a notional amount of $54,551. This was a tax-withholding disposition of vested RSUs rather than an open-market sale.

Key Details

• Transaction date: February 13, 2026
• Price: $1.75 per share
• Shares withheld/disposed: 31,172 — total value ≈ $54,551
• Footnote: Shares were withheld by the issuer to satisfy tax withholding on RSU vesting (F1)
• Filing date: February 18, 2026 — appears to be filed timely based on the reported dates
• Shares owned after the transaction: not specified in the provided filing excerpt

Context
A withholding transaction (SEC code F) is a routine step to cover tax obligations when restricted stock units vest; it is not the same as an active open-market sale and should not be interpreted alone as a change in insider sentiment.